- Additional information
What is Crisaborole?
Crisaborole is a phosphodiesterase- 4 (PDE4) inhibitor that was approved by the USFDA for the treatment of mild to moderate atopic dermatitis (AD) in patients aged two years and older.
Packing material for different products: Aluminium foil bag, HDPE bottle, Iron drum, or according to require
Shelf Life: 2 Years from production date
DMF: 30 mg/ml